These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 17005804

  • 1. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.
    Di Bonaventura G, Pompilio A, Picciani C, Iezzi M, D'Antonio D, Piccolomini R.
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3269-76. PubMed ID: 17005804
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
    Sun W, Su J, Xu S, Yan D.
    J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii.
    Cong L, Liao Y, Yang S, Yang R.
    Mycopathologia; 2017 Oct; 182(9-10):829-837. PubMed ID: 28144822
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sodium butyrate inhibits planktonic cells and biofilms of Trichosporon spp.
    Cordeiro RA, Aguiar ALR, Pereira VS, Pereira LMG, Portela FVM, Brilhante RSN, Camargo ZP, Sidrim JJC, Castelo-Branco DSCM, Rocha MFG.
    Microb Pathog; 2019 May; 130():219-225. PubMed ID: 30878621
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hospital Trichosporon asahii isolates with simple architecture biofilms and high resistance to antifungals routinely used in clinical practice.
    Malacrida AM, Corrêa JL, Barros ILE, Veiga FF, Pereira EDCA, Negri M, Svidzinski TIE.
    J Mycol Med; 2023 May; 33(2):101356. PubMed ID: 36563454
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients.
    Almeida AA, Crispim Bdo A, Grisolia AB, Svidzinski TI, Ortolani LG, Oliveira KM.
    Rev Argent Microbiol; 2016 May; 48(1):62-6. PubMed ID: 26916812
    [Abstract] [Full Text] [Related]

  • 15. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
    Ahangarkani F, Ilkit M, Vaseghi N, Zahedi N, Zomorodian K, Khodavaisy S, Afsarian MH, Abbasi K, de Groot T, Meis JF, Badali H.
    Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The antifungal effect of silver nanoparticles on Trichosporon asahii.
    Xia ZK, Ma QH, Li SY, Zhang DQ, Cong L, Tian YL, Yang RY.
    J Microbiol Immunol Infect; 2016 Apr; 49(2):182-8. PubMed ID: 24877597
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.